Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 7, 2025; 31(5): 101280
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101280
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101280
Table 4 Immunohistochemical results of patients with gastrointestinal schwannomas, n (%)
Variable | Overall |
S-100 (n = 209) | |
+ | 207 (99.0) |
- | 2 (1.0) |
SOX10 (n = 64) | |
+ | 64 (100.0) |
CD117 (n = 212) | |
- | 209 (98.6) |
+ (focal) | 3 (1.4) |
DOG-1 (n = 181) | |
- | 179 (98.9) |
+ (focal) | 2 (1.1) |
SMA (n = 205) | |
- | 187 (91.2) |
+ | 18 (8.8) |
Desmin (n = 186) | |
- | 171 (91.9) |
+ | 15 (8.1) |
Ki-67 (n = 183) | |
< 5% | 121 (66.1) |
5-10% | 61 (33.3) |
> 10% | 1 (0.6) |
SDHB (n = 46) | |
+ | 46 (100.0) |
HMB45 (n = 27) | |
- | 27 (100.0) |
- Citation: Zhang PC, Wang SH, Li J, Wang JJ, Chen HT, Li AQ. Clinicopathological features and treatment of gastrointestinal schwannomas. World J Gastroenterol 2025; 31(5): 101280
- URL: https://www.wjgnet.com/1007-9327/full/v31/i5/101280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i5.101280